Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolines

被引:25
作者
Hamann, LG
Winn, DT
Pooley, CLF
Tegley, CM
West, SJ
Farmer, LJ
Zhi, L
Edwards, JP
Marschke, KB
Mais, DE
Goldman, ME
Jones, TK
机构
[1] Ligand Pharmaceut Inc, Dept Med Chem, San Diego, CA 92121 USA
[2] Ligand Pharmaceut Inc, Dept New Leads Discovery, San Diego, CA 92121 USA
[3] Ligand Pharmaceut Inc, Dept Endocrine Res, San Diego, CA 92121 USA
关键词
D O I
10.1016/S0960-894X(98)00482-X
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of nonsteroidal human progesterone receptor (hPR) antagonists based on conformationally-restricted analogues of a 6-aryl-1,2-dihydro-2,2,4-trimethylquinoline pharmacophore were synthesized and evaluated for their ability to bind to the human progesterone receptor and inhibit progesterone-stimulated reporter gene expression in mammalian cells, (C) 1998 Elsevier Science Ltd. AU rights reserved.
引用
收藏
页码:2731 / 2736
页数:6
相关论文
共 24 条
[1]   Induction of a novel conformation in the progesterone receptor by ZK299 involves a defined region of the carboxyl-terminal tail [J].
Allan, GF ;
Lombardi, E ;
HaynesJohnson, D ;
Palmer, S ;
Kiddoe, M ;
Kraft, P ;
Campen, C ;
Rybczynski, P ;
Combs, DW ;
Phillips, A .
MOLECULAR ENDOCRINOLOGY, 1996, 10 (10) :1206-1213
[2]   INTERACTION OF GLUCOCORTICOID ANALOGS WITH THE HUMAN GLUCOCORTICOID RECEPTOR [J].
BERGER, TS ;
PARANDOOSH, Z ;
PERRY, BW ;
STEIN, RB .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 41 (3-8) :733-738
[3]  
BIGSBY RM, 1990, ATLA-ALTERN LAB ANIM, V18, P301
[4]   NONSTEROIDAL PROGESTERONE-RECEPTOR LIGANDS .2. HIGH-AFFINITY LIGANDS WITH SELECTIVITY FOR BONE CELL PROGESTERONE RECEPTORS [J].
COMBS, DW ;
REESE, K ;
CORNELIUS, LAM ;
GUNNET, JW ;
CRYAN, EV ;
GRANGER, KS ;
JORDAN, JJ ;
DEMAREST, KT .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (25) :4880-4884
[5]   NONSTEROIDAL PROGESTERONE-RECEPTOR LIGANDS .1. 3-ARYL-1-BENZOYL-1,4,5,6-TETRAHYDROPYRIDAZINES [J].
COMBS, DW ;
REESE, K ;
PHILLIPS, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (25) :4878-4879
[6]  
Connolly PJ, 1997, BIOORG MED CHEM LETT, V7, P2551, DOI 10.1016/S0960-894X(97)10016-6
[7]   5-aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists:: The effect of D-ring substituents [J].
Edwards, JP ;
West, SJ ;
Marschke, KB ;
Mais, DE ;
Gottardis, MM ;
Jones, TK .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (03) :303-310
[8]   Preparation, resolution, and biological evaluation of 5-aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines:: Potent, orally active, nonsteroidal progesterone receptor agonists [J].
Edwards, JP ;
Zhi, L ;
Pooley, CLF ;
Tegley, CM ;
West, SJ ;
Wang, MW ;
Gottardis, MM ;
Pathirana, C ;
Schrader, WT ;
Jones, TK .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) :2779-2785
[10]   Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl ether [J].
Hamann, LG ;
Farmer, LJ ;
Johnson, MG ;
Bender, SL ;
Mais, DE ;
Wang, MW ;
Crombie, D ;
Goldman, ME ;
Jones, TK .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (09) :1778-1789